|
|
|
Insider
Information: |
Frost Gregory Ian |
Relationship: |
SVP--Health Sector |
City: |
San Diego, |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
3,941,380 |
|
Indirect Shares
|
190,072 |
|
|
Direct
Value |
$166,023,962 |
|
|
Indirect Value
|
$8,644,475 |
|
|
Total
Shares |
4,131,452 |
|
|
Total
Value |
$174,668,437 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Halozyme Therapeutics Inc |
HALO |
CEO, President, Director |
2013-12-11 |
3,641,380 |
2004-03-11 |
190,072 |
Premium* |
|
Precigen Inc |
PGEN |
SVP--Health Sector |
2015-05-28 |
300,000 |
2014-02-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
87 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
HALO |
Halozyme Therapeutics Inc |
VP & Chief Scientific Ofcr |
|
2007-07-05 |
4 |
D |
$9.73 |
$6,743 |
D/D |
(693) |
2,944,606 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP & Chief Scientific Ofcr |
|
2007-07-06 |
4 |
OE |
$0.43 |
$11,235 |
D/D |
26,128 |
2,955,734 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP & Chief Scientific Ofcr |
|
2007-07-06 |
4 |
AS |
$9.65 |
$245,553 |
D/D |
(25,000) |
2,929,606 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP & Chief Scientific Ofcr |
|
2007-07-06 |
4 |
D |
$9.96 |
$11,235 |
D/D |
(1,128) |
2,954,606 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
|
2007-07-09 |
4 |
OE |
$0.43 |
$17,979 |
D/D |
41,812 |
2,971,418 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
|
2007-07-09 |
4 |
D |
$9.92 |
$17,975 |
D/D |
(1,812) |
2,969,606 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
|
2007-08-01 |
4 |
AS |
$7.92 |
$120,650 |
D/D |
(15,000) |
2,969,606 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
|
2007-08-01 |
4 |
OE |
$0.43 |
$6,816 |
D/D |
15,850 |
2,985,456 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
|
2007-08-01 |
4 |
D |
$8.01 |
$6,809 |
D/D |
(850) |
2,984,606 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
|
2007-08-02 |
4 |
AS |
$7.89 |
$29,467 |
D/D |
(3,700) |
2,980,906 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
|
2007-08-02 |
4/A |
AS |
$7.99 |
$100,951 |
D/D |
(12,601) |
2,969,606 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
|
2007-08-02 |
4 |
D |
$8.33 |
$6,797 |
D/D |
(816) |
2,984,606 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
|
2007-08-02 |
4 |
OE |
$0.43 |
$6,801 |
D/D |
15,816 |
2,985,422 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
|
2007-08-06 |
4 |
D |
$8.20 |
$22,689 |
D/D |
(2,767) |
3,019,606 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
|
2007-08-06 |
4 |
OE |
$0.43 |
$22,690 |
D/D |
52,767 |
3,022,373 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
|
2007-08-29 |
4 |
AS |
$8.16 |
$124,185 |
D/D |
(15,000) |
3,019,606 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
|
2007-08-29 |
4 |
D |
$8.48 |
$6,792 |
D/D |
(801) |
3,034,606 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
|
2007-08-29 |
4 |
OE |
$0.43 |
$6,794 |
D/D |
15,801 |
3,035,407 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
|
2007-08-30 |
4 |
AS |
$8.34 |
$126,752 |
D/D |
(15,000) |
3,019,606 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
|
2007-08-30 |
4 |
OE |
$0.43 |
$6,800 |
D/D |
15,815 |
3,035,421 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
|
2007-08-30 |
4 |
D |
$8.34 |
$6,797 |
D/D |
(815) |
3,034,606 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
|
2007-09-26 |
4 |
AS |
$8.93 |
$135,864 |
D/D |
(15,000) |
3,019,606 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
|
2007-09-26 |
4 |
D |
$9.07 |
$6,766 |
D/D |
(746) |
3,034,606 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
|
2007-09-26 |
4 |
OE |
$0.43 |
$6,771 |
D/D |
15,746 |
3,035,352 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
|
2007-09-27 |
4 |
OE |
$0.43 |
$6,776 |
D/D |
15,757 |
3,035,363 |
0 |
- |
|
87 Records found
|
|
Page 2 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|